Psilocybin Therapy in New Mexico

How It Works

Treatment follows a mandatory three-session structure: a preparation session, an administration session where psilocybin is consumed under clinical supervision in a DOH-approved setting, and an integration session afterward. Only naturally occurring psilocybin from mushrooms is permitted — synthetic psilocybin and analogs are explicitly banned. All psilocybin must be cultivated and produced within New Mexico by licensed producers.

Qualifying Conditions

Patients must be diagnosed with one of four qualifying conditions:

• Treatment-resistant depression
• Post-traumatic stress disorder (PTSD)
• Substance use disorders
• End-of-life psychological distress

The Medical Psilocybin Advisory Board may recommend additional conditions in the future.

Provider Requirements

Clinicians must be licensed New Mexico healthcare providers who hold an additional DOH permit specific to psilocybin services. This dual-licensing requirement is significantly more restrictive than Oregon's facilitator model (which requires only a high school diploma and ~120 hours of training) and Colorado's general facilitator track (150 hours of training). New Mexico essentially builds psilocybin therapy into the existing medical licensure infrastructure.

Expected Costs

No New Mexico-specific pricing has been established yet. Based on Oregon and Colorado benchmarks: individual sessions typically run $1,000–$3,500 in Oregon. Colorado programs range $1,500–$4,500 per session, with full programs reaching $3,500–$9,500. Insurance will not cover psilocybin therapy until federal FDA approval. The law created a $1 million Medical Psilocybin Treatment Equity Fund to subsidize treatment for qualifying low-income patients.

Insurance & Payment

Psilocybin therapy will not be covered by insurance until federal FDA approval. Medicaid, Medicare, and private insurance cannot cover this therapy until psilocybin is FDA-approved. The $1 million Treatment Equity Fund provides a modest bridge for low-income patients. The law also provides a gross receipts tax deduction for psilocybin products and services, aligning their tax treatment with prescription drugs and medical cannabis.

Rulemaking Status

The program is housed within the DOH's Center for Medical Cannabis and Psilocybin, directed by Dominick Zurlo. The nine-member Medical Psilocybin Advisory Board is tasked with recommending qualifying conditions, dosage standards, and best practices. No patient application process or licensing framework is available yet. Rules will be published at nmhealth.org.

Cities to Watch

• Santa Fe — DOH program office, Limina Foundation, September 2025 “Enchanted State” conference (800+ attendees)
• Albuquerque — Largest population center, multiple ketamine clinics, UNM psychedelic research legacy
• Las Cruces — SB 219 co-sponsor Sen. Steinborn, Sol Tryp nonprofit, Mariposa Counseling headquarters

Providers Positioning for Launch

• Mariposa Counseling Center (Las Cruces) — Already offering psilocybin-assisted retreats under a 2005 NM Court ruling
• Sol Tryp (Las Cruces) — 501(c)(3) ketamine therapy nonprofit, SB 219 advocate
• Tranquility Ketamine (Albuquerque)
• Injection & Infusion Clinic of ABQ — 2,000+ ketamine infusions since 2017
• Blue Sky Ketamine & Insight Ketamine (Santa Fe)
• Klarisana — Operating in three NM cities